Shearman & Sterling advised underwriters Morgan Stanley, J.P. Morgan, BofA Merrill Lynch, Goldman, Sachs & Co., Jefferies, Deutsche Bank Securities, Blackstone Capital Markets, Piper Jaffray, Raymond James, Wells Fargo Securities, William Blair and Evercore in connection with the initial public offering of 42,500,000 shares of common stock of Catalent, Inc. The offering raised $871,250,000 and the shares have been listed on the New York Stock Exchange.
Catalent, Inc. is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.
The following Shearman & Sterling team advised the underwriters in the transaction: partners Michael Benjamin (New York-Capital Markets), Russell Sacks (New York- Financial Institutions Advisory & Financial Regulatory), and Doreen Lilienfeld (New York-Executive Compensation & Employee Benefits); associates Merritt Johnson (New York-Capital Markets), Christina Leto-Feist (New York-Capital Markets), Jennifer Morton (New York- Financial Institutions Advisory & Financial Regulatory), Gary Tashjian (New York-Executive Compensation & Employee Benefits), Daniel Smith (New York-Tax), Leo Wong (New York-Corporate), Justin Glick (New York-Corporate), and Jenny Ding (New York-Corporate); and visiting attorney Yoshihito Kuramochi (New York-Capital Markets).
